Optivantage DH Contrast Media Injector is a medical device intended for use by qualified healthcare professionals; it is a contrast delivery system and is designed to inject radiopaque contrast media into a patient's vascular system to obtain diagnostic images when used with computed tomography (i.e. "CT") equipment.
For complete information about precautions and optimal usage conditions, we recommend consulting the instructions for use supplied with the device or by your local Guerbet representative(s). For use only in countries with applicable health authority registrations.
TÜV SÜD 0123
Manufacturer: Liebel-Flarsheim Company LLC
EC Rep: Guerbet
OptiVantage™, OptiBolus®, OptiProtect™, LF™, Contrast&Care® are trademarks of Guerbet. Patents pending and issued patents. © Copyright 2018 Guerbet – All rights reserved. Document modification date: December 2022 - P22001827.
1. Certified by Guerbet as compatible on Guerbet injectors - data on file
2. Clinical Cases mentioned in the following document: https://www.guerbet.com/media/a0fnjjmm/optibolus-case-studies.pdf
1st Case: Courtesy of Chelsea Westminster Hospital NHS Foundation Trust
2nd case: Courtesy of Colin Monaghan, CT Superintendent, Liverpool Heart & Chest Hospital NHS Foundation Trust
3rd case: Courtesy of Chest & Westminster Hospital NHS Foundation Trust
4th case: Courtesy of Colin Monaghan, CT Superintendent, Liverpool Heart & Chest Hospital NHS Foundation Trust
3. Internal data: Cattini G.H and Walsh A. - A bolus shaping software used to reduce the amount of contrast given to patients during CT exams without reducing the diagnostic confidence (2010)
Navin, P, Murray, A.M, Nandikumar, K, Waldron, R, Tuohy, B., Shaped-bolus protocol reduces contrast medium volume in abdominal CT while maintaining image quality - Clinical Radiology (Oct 2016)